Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Phase I). Showing records 1 – 30 of 133 total matches.

[1] [2] [3] [4] [5]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Illinois – Chicago

1. Danciu, Oana. Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies.

Degree: 2018, University of Illinois – Chicago

 The primary objective of this study was to determine the maximum tolerated dose (MTD) of first procaspase-activating compound (PAC-1) in patients with advanced malignancy by… (more)

Subjects/Keywords: phase I; tumor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Danciu, O. (2018). Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies. (Thesis). University of Illinois – Chicago. Retrieved from http://hdl.handle.net/10027/22612

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Danciu, Oana. “Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies.” 2018. Thesis, University of Illinois – Chicago. Accessed April 10, 2021. http://hdl.handle.net/10027/22612.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Danciu, Oana. “Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies.” 2018. Web. 10 Apr 2021.

Vancouver:

Danciu O. Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies. [Internet] [Thesis]. University of Illinois – Chicago; 2018. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/10027/22612.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Danciu O. Phase I Study of Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies. [Thesis]. University of Illinois – Chicago; 2018. Available from: http://hdl.handle.net/10027/22612

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Alberta

2. Benjaminy, Shelly. Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials.

Degree: MS, School of Public Health Sciences, 2013, University of Alberta

I investigate how to ethically communicate about a phase I gene transfer trial for choroideremia, a blinding retinopathy, in light of this novel biotechnology’s portrayal… (more)

Subjects/Keywords: phase I; choroideremia; media; gene transfer; ethics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Benjaminy, S. (2013). Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/x633f269n

Chicago Manual of Style (16th Edition):

Benjaminy, Shelly. “Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials.” 2013. Masters Thesis, University of Alberta. Accessed April 10, 2021. https://era.library.ualberta.ca/files/x633f269n.

MLA Handbook (7th Edition):

Benjaminy, Shelly. “Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials.” 2013. Web. 10 Apr 2021.

Vancouver:

Benjaminy S. Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials. [Internet] [Masters thesis]. University of Alberta; 2013. [cited 2021 Apr 10]. Available from: https://era.library.ualberta.ca/files/x633f269n.

Council of Science Editors:

Benjaminy S. Ocular gene transfer communications: Developing ethical frameworks for phase I choroideremia clinical trials. [Masters Thesis]. University of Alberta; 2013. Available from: https://era.library.ualberta.ca/files/x633f269n

3. Costa, Marisa Boff da. Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios.

Degree: 2012, Brazil

Introdução: O processo de peguilação consiste de um método de modificação da estrutura proteica com o propósito de minimizar muitas das limitações que estão associadas… (more)

Subjects/Keywords: Interferon alfa; Farmacocinética; Pharmacokinetics; Alfapeginterferon; Phase I

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Costa, M. B. d. (2012). Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios. (Masters Thesis). Brazil. Retrieved from http://hdl.handle.net/10183/61890

Chicago Manual of Style (16th Edition):

Costa, Marisa Boff da. “Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios.” 2012. Masters Thesis, Brazil. Accessed April 10, 2021. http://hdl.handle.net/10183/61890.

MLA Handbook (7th Edition):

Costa, Marisa Boff da. “Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios.” 2012. Web. 10 Apr 2021.

Vancouver:

Costa MBd. Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios. [Internet] [Masters thesis]. Brazil; 2012. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/10183/61890.

Council of Science Editors:

Costa MBd. Comparação farmacocinética de duas formulações de alfapeginterferona em voluntários sadios. [Masters Thesis]. Brazil; 2012. Available from: http://hdl.handle.net/10183/61890


Virginia Tech

4. Chen, Yajuan. Cluster_Based Profile Monitoring in Phase I Analysis.

Degree: PhD, Statistics, 2014, Virginia Tech

 Profile monitoring is a well-known approach used in statistical process control where the quality of the product or process is characterized by a profile or… (more)

Subjects/Keywords: Cluster; Mixed Model; Phase I; Phase II; Robust; T2 Statistic

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, Y. (2014). Cluster_Based Profile Monitoring in Phase I Analysis. (Doctoral Dissertation). Virginia Tech. Retrieved from http://hdl.handle.net/10919/46810

Chicago Manual of Style (16th Edition):

Chen, Yajuan. “Cluster_Based Profile Monitoring in Phase I Analysis.” 2014. Doctoral Dissertation, Virginia Tech. Accessed April 10, 2021. http://hdl.handle.net/10919/46810.

MLA Handbook (7th Edition):

Chen, Yajuan. “Cluster_Based Profile Monitoring in Phase I Analysis.” 2014. Web. 10 Apr 2021.

Vancouver:

Chen Y. Cluster_Based Profile Monitoring in Phase I Analysis. [Internet] [Doctoral dissertation]. Virginia Tech; 2014. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/10919/46810.

Council of Science Editors:

Chen Y. Cluster_Based Profile Monitoring in Phase I Analysis. [Doctoral Dissertation]. Virginia Tech; 2014. Available from: http://hdl.handle.net/10919/46810

5. Esnault, Olivier. Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -.

Degree: Docteur es, Biologie humaine. recherche clinique, 2009, Université Claude Bernard – Lyon I

La grande fréquence des nodules thyroïdiens et la relative agressivité des traitements conventionnels ont motivé l'étude d'une méthode non invasive utilisant des Ultrasons Focalisés (HIFU).… (more)

Subjects/Keywords: HIFU; Brebis; Essai animal; Essai de phase I; Nodule thyroïdien; HIFU; Ewe; Animal test; Phase I trial; Thyroid nodule; 610

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Esnault, O. (2009). Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -. (Doctoral Dissertation). Université Claude Bernard – Lyon I. Retrieved from http://www.theses.fr/2009LYO10340

Chicago Manual of Style (16th Edition):

Esnault, Olivier. “Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -.” 2009. Doctoral Dissertation, Université Claude Bernard – Lyon I. Accessed April 10, 2021. http://www.theses.fr/2009LYO10340.

MLA Handbook (7th Edition):

Esnault, Olivier. “Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -.” 2009. Web. 10 Apr 2021.

Vancouver:

Esnault O. Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -. [Internet] [Doctoral dissertation]. Université Claude Bernard – Lyon I; 2009. [cited 2021 Apr 10]. Available from: http://www.theses.fr/2009LYO10340.

Council of Science Editors:

Esnault O. Thérapeutique par ultrasons focalisés de haute intensité (HIFU) appliquée à la thyroïde : de l’expérimentation animale à l’essai humain : -. [Doctoral Dissertation]. Université Claude Bernard – Lyon I; 2009. Available from: http://www.theses.fr/2009LYO10340

6. AndrÃa Vieira Pontes Rohleder. Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino.

Degree: PhD, 2014, Universidade Federal do Ceará

O ensaio clÃnico fase I Ã a primeira etapa de teste de medicamentos em seres humanos, visando determinar principalmente a seguranÃa associada a doses crescentes… (more)

Subjects/Keywords: FARMACOLOGIA; Ensaio ClÃnico Fase I; SeguranÃa; Efeitos adversos; Clinical Trial, Phase I; Safety; Adverse effects

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rohleder, A. V. P. (2014). Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino. (Doctoral Dissertation). Universidade Federal do Ceará. Retrieved from http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=13615 ;

Chicago Manual of Style (16th Edition):

Rohleder, AndrÃa Vieira Pontes. “Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino.” 2014. Doctoral Dissertation, Universidade Federal do Ceará. Accessed April 10, 2021. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=13615 ;.

MLA Handbook (7th Edition):

Rohleder, AndrÃa Vieira Pontes. “Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino.” 2014. Web. 10 Apr 2021.

Vancouver:

Rohleder AVP. Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino. [Internet] [Doctoral dissertation]. Universidade Federal do Ceará 2014. [cited 2021 Apr 10]. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=13615 ;.

Council of Science Editors:

Rohleder AVP. Estudo fase I para avaliar a seguranÃa e tolerabilidade do LABCAT TCJUSS administrado por via oral em voluntÃrios sadios do sexo masculino. [Doctoral Dissertation]. Universidade Federal do Ceará 2014. Available from: http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=13615 ;


Boston University

7. Malesz, Alexandra Elizabeth. Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study.

Degree: MS, Medical Sciences, 2016, Boston University

 OBJECTIVE: The aim of this study was to investigate the safety and tolerability of a novel anti-folate drug, pemetrexed, in the setting of a phase(more)

Subjects/Keywords: Oncology; Pemetrexed; Phase I clinical trial; Primary CNS lymphoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Malesz, A. E. (2016). Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/19487

Chicago Manual of Style (16th Edition):

Malesz, Alexandra Elizabeth. “Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study.” 2016. Masters Thesis, Boston University. Accessed April 10, 2021. http://hdl.handle.net/2144/19487.

MLA Handbook (7th Edition):

Malesz, Alexandra Elizabeth. “Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study.” 2016. Web. 10 Apr 2021.

Vancouver:

Malesz AE. Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study. [Internet] [Masters thesis]. Boston University; 2016. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/2144/19487.

Council of Science Editors:

Malesz AE. Pemetrexed in primary central nervous system lymphoma: a phase-I dose finding study. [Masters Thesis]. Boston University; 2016. Available from: http://hdl.handle.net/2144/19487


University of Cincinnati

8. Moorthy, Ganesh. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2015, University of Cincinnati

 Dysregulation of PI3K/Akt/mTOR pathway has been implicated in tumorigenesis and malignancy in numerous solid tumors. Everolimus is a potent allosteric inhibitor of mTORC1, and has… (more)

Subjects/Keywords: Pharmaceuticals; pharmacokinetics; Phase I; PBPK; DDI; BEZ235; Everolimus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Moorthy, G. (2015). Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1439296033

Chicago Manual of Style (16th Edition):

Moorthy, Ganesh. “Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment.” 2015. Doctoral Dissertation, University of Cincinnati. Accessed April 10, 2021. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1439296033.

MLA Handbook (7th Edition):

Moorthy, Ganesh. “Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment.” 2015. Web. 10 Apr 2021.

Vancouver:

Moorthy G. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment. [Internet] [Doctoral dissertation]. University of Cincinnati; 2015. [cited 2021 Apr 10]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1439296033.

Council of Science Editors:

Moorthy G. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-clinical Mechanistic Assessment. [Doctoral Dissertation]. University of Cincinnati; 2015. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1439296033


North-West University

9. Crous, Ané. The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous.

Degree: 2013, North-West University

 Sulforaphane is an isothiocyanate found in high concentrations in cruciferous vegetables like broccoli. Sulforaphane has received much attention due to the evidence that it inhibits… (more)

Subjects/Keywords: Sulforaphane; oxidative stress; t-BHP; MTT; phase I and phase II; biotransformation; LC-ESI-MS/MS; HepaRG cells

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Crous, A. (2013). The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous. (Thesis). North-West University. Retrieved from http://hdl.handle.net/10394/9642

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Crous, Ané. “The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous. ” 2013. Thesis, North-West University. Accessed April 10, 2021. http://hdl.handle.net/10394/9642.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Crous, Ané. “The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous. ” 2013. Web. 10 Apr 2021.

Vancouver:

Crous A. The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous. [Internet] [Thesis]. North-West University; 2013. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/10394/9642.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Crous A. The effect of sulforaphane on oxidative stress and biotransformation in HepaRG cells / A. Crous. [Thesis]. North-West University; 2013. Available from: http://hdl.handle.net/10394/9642

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

10. ZHAO XINYUAN. Infeasible potential reduction algorithms for semidefinite programming.

Degree: 2005, National University of Singapore

Subjects/Keywords: Potential Reduction function; Semidefinite Programming; phase I; phase II.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

XINYUAN, Z. (2005). Infeasible potential reduction algorithms for semidefinite programming. (Thesis). National University of Singapore. Retrieved from https://scholarbank.nus.edu.sg/handle/10635/160988

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

XINYUAN, ZHAO. “Infeasible potential reduction algorithms for semidefinite programming.” 2005. Thesis, National University of Singapore. Accessed April 10, 2021. https://scholarbank.nus.edu.sg/handle/10635/160988.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

XINYUAN, ZHAO. “Infeasible potential reduction algorithms for semidefinite programming.” 2005. Web. 10 Apr 2021.

Vancouver:

XINYUAN Z. Infeasible potential reduction algorithms for semidefinite programming. [Internet] [Thesis]. National University of Singapore; 2005. [cited 2021 Apr 10]. Available from: https://scholarbank.nus.edu.sg/handle/10635/160988.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

XINYUAN Z. Infeasible potential reduction algorithms for semidefinite programming. [Thesis]. National University of Singapore; 2005. Available from: https://scholarbank.nus.edu.sg/handle/10635/160988

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

11. Daniela Aparecida Lorencini. Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal.

Degree: 2019, University of São Paulo

A nefrolitíase é uma doença comum e recorrente com prevalência mundial variando de 5 a 20%, com pico de incidência entre a 3ª e 4ª… (more)

Subjects/Keywords: Cálculos renais; Eficácia; Ensaio clínico fase I; Fabaceae; Nefrolitíase; Segurança; Efficacy; Kidney stones , Fabaceae; Nephrolithiasis; Phase I clinical trial; Safety

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lorencini, D. A. (2019). Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/17/17138/tde-05082019-113049/

Chicago Manual of Style (16th Edition):

Lorencini, Daniela Aparecida. “Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal.” 2019. Masters Thesis, University of São Paulo. Accessed April 10, 2021. http://www.teses.usp.br/teses/disponiveis/17/17138/tde-05082019-113049/.

MLA Handbook (7th Edition):

Lorencini, Daniela Aparecida. “Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal.” 2019. Web. 10 Apr 2021.

Vancouver:

Lorencini DA. Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal. [Internet] [Masters thesis]. University of São Paulo; 2019. [cited 2021 Apr 10]. Available from: http://www.teses.usp.br/teses/disponiveis/17/17138/tde-05082019-113049/.

Council of Science Editors:

Lorencini DA. Estudo clínico fase I/II de segurança e eficácia de um medicamento inovador para tratamento de litíase renal. [Masters Thesis]. University of São Paulo; 2019. Available from: http://www.teses.usp.br/teses/disponiveis/17/17138/tde-05082019-113049/


Université Paris-Sud – Paris XI

12. Ezzalfani Gahlouzi, Monia. Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology.

Degree: Docteur es, Santé publique, 2013, Université Paris-Sud – Paris XI

 Le but principal d'un essai de phase I en oncologie est d'identifier, parmi un nombre fini de doses, la dose à recommander d'un nouveau traitement… (more)

Subjects/Keywords: Méthode de Phase I; Oncologie; Thérapie ciblée; CRM; QLCRM; Score de toxicité; Quasi-Bernoulli; Phase I Designs; Oncology; Targeted therapies; CRM; QLCRM; Toxicity score; Quasi-Bernoulli

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ezzalfani Gahlouzi, M. (2013). Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology. (Doctoral Dissertation). Université Paris-Sud – Paris XI. Retrieved from http://www.theses.fr/2013PA11T060

Chicago Manual of Style (16th Edition):

Ezzalfani Gahlouzi, Monia. “Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology.” 2013. Doctoral Dissertation, Université Paris-Sud – Paris XI. Accessed April 10, 2021. http://www.theses.fr/2013PA11T060.

MLA Handbook (7th Edition):

Ezzalfani Gahlouzi, Monia. “Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology.” 2013. Web. 10 Apr 2021.

Vancouver:

Ezzalfani Gahlouzi M. Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology. [Internet] [Doctoral dissertation]. Université Paris-Sud – Paris XI; 2013. [cited 2021 Apr 10]. Available from: http://www.theses.fr/2013PA11T060.

Council of Science Editors:

Ezzalfani Gahlouzi M. Développement d’une méthode de recherche de dose modélisant un score de toxicité pour les essais cliniques de phase I en Oncologie : Development of dose-finding method based on a toxicity score for designs evaluating molecularly targeted therapies in oncology. [Doctoral Dissertation]. Université Paris-Sud – Paris XI; 2013. Available from: http://www.theses.fr/2013PA11T060

13. Cunanan, Kristen. Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials.

Degree: PhD, Biostatistics, 2015, University of Minnesota

 Bayesian adaptive clinical trial designs are slowly gaining momentum in practice due to their accuracy, flexibility and efficiency in evaluating a novel drug. In this… (more)

Subjects/Keywords: Adaptive Designs; Bayesian Methods; Phase I; Phase I-II

…investigation before approval. The “early” and “middle” phase (Phase I and Phase II in the U.S… …methods for early phase cancer clinical trials. 1.1 Phase I Clinical Trials The primary… …objective of a Phase I clinical trial is to evaluate the safety profile of a novel treatment and… …in Phase I cancer trials). The primary endpoint in Phase I clinical trials is… …prevent increasing the dosage. In Phase I oncology trials, investigators define adverse events… 

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cunanan, K. (2015). Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials. (Doctoral Dissertation). University of Minnesota. Retrieved from http://hdl.handle.net/11299/175408

Chicago Manual of Style (16th Edition):

Cunanan, Kristen. “Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials.” 2015. Doctoral Dissertation, University of Minnesota. Accessed April 10, 2021. http://hdl.handle.net/11299/175408.

MLA Handbook (7th Edition):

Cunanan, Kristen. “Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials.” 2015. Web. 10 Apr 2021.

Vancouver:

Cunanan K. Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials. [Internet] [Doctoral dissertation]. University of Minnesota; 2015. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/11299/175408.

Council of Science Editors:

Cunanan K. Novel Bayesian Adaptive Designs for Early Phase Oncology Clinical Trials. [Doctoral Dissertation]. University of Minnesota; 2015. Available from: http://hdl.handle.net/11299/175408

14. Clertant, Matthieu. Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose.

Degree: Docteur es, Mathématiques, 2016, Université Pierre et Marie Curie – Paris VI

Les Phases I sont un domaine des essais cliniques dans lequel les statisticiens ont encore beaucoup à apporter. Depuis trente ans, ce secteur bénéficie d'un… (more)

Subjects/Keywords: Méthode séquentielle; Essai clinique; Modèle bayésien hiérarchique; Modèle semi-Paramétrique; Phase I; Positionnement de dose; Dose finding; Hierarchical bayesian model; Phase I; 510

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Clertant, M. (2016). Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose. (Doctoral Dissertation). Université Pierre et Marie Curie – Paris VI. Retrieved from http://www.theses.fr/2016PA066230

Chicago Manual of Style (16th Edition):

Clertant, Matthieu. “Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose.” 2016. Doctoral Dissertation, Université Pierre et Marie Curie – Paris VI. Accessed April 10, 2021. http://www.theses.fr/2016PA066230.

MLA Handbook (7th Edition):

Clertant, Matthieu. “Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose.” 2016. Web. 10 Apr 2021.

Vancouver:

Clertant M. Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose. [Internet] [Doctoral dissertation]. Université Pierre et Marie Curie – Paris VI; 2016. [cited 2021 Apr 10]. Available from: http://www.theses.fr/2016PA066230.

Council of Science Editors:

Clertant M. Semi-parametric bayesian model, applications in dose finding studies : Modèle bayésien semi-paramétrique, applications en positionnement de dose. [Doctoral Dissertation]. Université Pierre et Marie Curie – Paris VI; 2016. Available from: http://www.theses.fr/2016PA066230


Universiteit Utrecht

15. Boss, D.S. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.

Degree: 2009, Universiteit Utrecht

 With the emergence of novel, rationally designed anti-cancer drugs there is also a need for novel endpoints when evaluating these drugs in clinical trials. The… (more)

Subjects/Keywords: Farmacie; Drug Development; PET/CT; Phase I studies; Pharmacokinetics; Pharmacodynamics; Clinical trials; Cancer; Targeted therapy

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boss, D. S. (2009). Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/37369

Chicago Manual of Style (16th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Doctoral Dissertation, Universiteit Utrecht. Accessed April 10, 2021. http://dspace.library.uu.nl:8080/handle/1874/37369.

MLA Handbook (7th Edition):

Boss, D S. “Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs.” 2009. Web. 10 Apr 2021.

Vancouver:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2009. [cited 2021 Apr 10]. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369.

Council of Science Editors:

Boss DS. Safety, pharmacokinetics and pharmacodynamics of targeted anti-cancer drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2009. Available from: http://dspace.library.uu.nl:8080/handle/1874/37369


University of Manitoba

16. Zhang, Weijia. Novel statistical designs for phase I clinical trials.

Degree: Statistics, 2019, University of Manitoba

 A clinical trial is an experiment on human subjects designed to evaluate the safety and efficacy of a new drug or medical intervention. There are… (more)

Subjects/Keywords: Bayesian method; CRM; Maximum tolerated dose; Phase I clinical trials; Toxicity probability

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, W. (2019). Novel statistical designs for phase I clinical trials. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/34170

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Zhang, Weijia. “Novel statistical designs for phase I clinical trials.” 2019. Thesis, University of Manitoba. Accessed April 10, 2021. http://hdl.handle.net/1993/34170.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Zhang, Weijia. “Novel statistical designs for phase I clinical trials.” 2019. Web. 10 Apr 2021.

Vancouver:

Zhang W. Novel statistical designs for phase I clinical trials. [Internet] [Thesis]. University of Manitoba; 2019. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/1993/34170.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Zhang W. Novel statistical designs for phase I clinical trials. [Thesis]. University of Manitoba; 2019. Available from: http://hdl.handle.net/1993/34170

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Univerzitet u Beogradu

17. Milanović, Zorana Z., 1989-. Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis.

Degree: Fakultet veterinarske medicine, 2018, Univerzitet u Beogradu

Veterinarska medicina - Patološka fiziologija / Veterinary medicine - Pathophysiology

Najveći broj ispitivanja kod ljudi i životinja ukazuje da tokom odgovora akutne faze dolazi do… (more)

Subjects/Keywords: inflammation; Acute phase proteins; HDL; LDL; Serum amyloid A; apolipoprotein A-I

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Milanović, Zorana Z., 1. (2018). Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis. (Thesis). Univerzitet u Beogradu. Retrieved from https://fedorabg.bg.ac.rs/fedora/get/o:19059/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Milanović, Zorana Z., 1989-. “Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis.” 2018. Thesis, Univerzitet u Beogradu. Accessed April 10, 2021. https://fedorabg.bg.ac.rs/fedora/get/o:19059/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Milanović, Zorana Z., 1989-. “Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis.” 2018. Web. 10 Apr 2021.

Vancouver:

Milanović, Zorana Z. 1. Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis. [Internet] [Thesis]. Univerzitet u Beogradu; 2018. [cited 2021 Apr 10]. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19059/bdef:Content/get.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Milanović, Zorana Z. 1. Disproteinemija i dislipoproteinemija tokom odgovora akutne faze kod pasa prirodno inficiranih sa Babesia canis. [Thesis]. Univerzitet u Beogradu; 2018. Available from: https://fedorabg.bg.ac.rs/fedora/get/o:19059/bdef:Content/get

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manitoba

18. Zhang, Weijia. Statistical design of phase I clinical trials.

Degree: Statistics, 2016, University of Manitoba

 My MSc thesis is focused on parametric designs of Phase I clinical trials, using the continual reassessment method. A parametric model with unknown parameters is… (more)

Subjects/Keywords: Phase I clinical trials; Continual reassessment method; Bayesian method; Toxicity; Maximum tolerated dose

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zhang, W. (2016). Statistical design of phase I clinical trials. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/31795

Chicago Manual of Style (16th Edition):

Zhang, Weijia. “Statistical design of phase I clinical trials.” 2016. Masters Thesis, University of Manitoba. Accessed April 10, 2021. http://hdl.handle.net/1993/31795.

MLA Handbook (7th Edition):

Zhang, Weijia. “Statistical design of phase I clinical trials.” 2016. Web. 10 Apr 2021.

Vancouver:

Zhang W. Statistical design of phase I clinical trials. [Internet] [Masters thesis]. University of Manitoba; 2016. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/1993/31795.

Council of Science Editors:

Zhang W. Statistical design of phase I clinical trials. [Masters Thesis]. University of Manitoba; 2016. Available from: http://hdl.handle.net/1993/31795


University of Southern California

19. Venkatramani, Rajkumar. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.

Degree: MS, Preventive Medicine (Health Behavior), 2010, University of Southern California

 Vincristine, irinotecan and temozolomide have been used in various combinations to treat pediatric solid tumors. These combinations, in general have been well tolerated. Outcomes for… (more)

Subjects/Keywords: phase I study; clinical trial; bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Venkatramani, R. (2010). A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296

Chicago Manual of Style (16th Edition):

Venkatramani, Rajkumar. “A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.” 2010. Masters Thesis, University of Southern California. Accessed April 10, 2021. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296.

MLA Handbook (7th Edition):

Venkatramani, Rajkumar. “A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.” 2010. Web. 10 Apr 2021.

Vancouver:

Venkatramani R. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. [Internet] [Masters thesis]. University of Southern California; 2010. [cited 2021 Apr 10]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296.

Council of Science Editors:

Venkatramani R. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. [Masters Thesis]. University of Southern California; 2010. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296


University of Georgia

20. Cao, Luan Thanh. Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217.

Degree: 2014, University of Georgia

 This study aims to compare the subsurface and pedestrian methods used in Phase I archaeological survey in B. F. Grant Memorial Forest, Putnam County, Georgia.… (more)

Subjects/Keywords: Archaeology Survey; Phase I; Putnam County; Shovel Testing; Bishop F. Grant Memorial Forest

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cao, L. T. (2014). Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217. (Thesis). University of Georgia. Retrieved from http://hdl.handle.net/10724/28995

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Cao, Luan Thanh. “Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217.” 2014. Thesis, University of Georgia. Accessed April 10, 2021. http://hdl.handle.net/10724/28995.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Cao, Luan Thanh. “Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217.” 2014. Web. 10 Apr 2021.

Vancouver:

Cao LT. Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217. [Internet] [Thesis]. University of Georgia; 2014. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/10724/28995.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Cao LT. Archaeological subsurface survey in B. F. Grant Memorial Forest: Area 4, Stand 217. [Thesis]. University of Georgia; 2014. Available from: http://hdl.handle.net/10724/28995

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Northeastern University

21. Fukuda, Hiroki. Droplet-based processing of magnesium alloys for the production of high-performance bulk materials.

Degree: PhD, Department of Mechanical and Industrial Engineering, 2009, Northeastern University

 The magnesium consumption worldwide has been rapidly increasing in the recent years as magnesium alloys replace other materials in a variety of structural applications in… (more)

Subjects/Keywords: I-Phase; Mg-Zn-Y; UDS; W-Phase; X-Phase; Engineering; Mechanical Engineering

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fukuda, H. (2009). Droplet-based processing of magnesium alloys for the production of high-performance bulk materials. (Doctoral Dissertation). Northeastern University. Retrieved from http://hdl.handle.net/2047/d20000640

Chicago Manual of Style (16th Edition):

Fukuda, Hiroki. “Droplet-based processing of magnesium alloys for the production of high-performance bulk materials.” 2009. Doctoral Dissertation, Northeastern University. Accessed April 10, 2021. http://hdl.handle.net/2047/d20000640.

MLA Handbook (7th Edition):

Fukuda, Hiroki. “Droplet-based processing of magnesium alloys for the production of high-performance bulk materials.” 2009. Web. 10 Apr 2021.

Vancouver:

Fukuda H. Droplet-based processing of magnesium alloys for the production of high-performance bulk materials. [Internet] [Doctoral dissertation]. Northeastern University; 2009. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/2047/d20000640.

Council of Science Editors:

Fukuda H. Droplet-based processing of magnesium alloys for the production of high-performance bulk materials. [Doctoral Dissertation]. Northeastern University; 2009. Available from: http://hdl.handle.net/2047/d20000640


Universidade Estadual de Campinas

22. Sarti Sprogis, Adriane Cristina, 1967-. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis.

Degree: Faculdade de Ciências Médicas; Programa de Pós-Graduação em Clínica Médica, 2014, Universidade Estadual de Campinas

Orientadores: Marcelo Brocchi, Gustavo Bueno Gregoracci

Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas

Made available in DSpace on 2018-08-24T09:27:26Z (GMT). No.… (more)

Subjects/Keywords: Salmonella enterica Enteritidis; Salmonella enterica 4,[5],12:i:-; Variação de fase flagelar; Bacteriófagos; Salmonella enterica Enteritidis; Salmonella enterica I,4,[5],12:i:-; Flagellar phase variation; Bacteriophages

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Sarti Sprogis, Adriane Cristina, 1. (2014). Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. (Masters Thesis). Universidade Estadual de Campinas. Retrieved from SARTI SPROGIS, Adriane Cristina. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. 2014. 131 p. Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/310660>. Acesso em: 24 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/310660

Chicago Manual of Style (16th Edition):

Sarti Sprogis, Adriane Cristina, 1967-. “Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis.” 2014. Masters Thesis, Universidade Estadual de Campinas. Accessed April 10, 2021. SARTI SPROGIS, Adriane Cristina. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. 2014. 131 p. Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/310660>. Acesso em: 24 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/310660.

MLA Handbook (7th Edition):

Sarti Sprogis, Adriane Cristina, 1967-. “Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis.” 2014. Web. 10 Apr 2021.

Vancouver:

Sarti Sprogis, Adriane Cristina 1. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. [Internet] [Masters thesis]. Universidade Estadual de Campinas; 2014. [cited 2021 Apr 10]. Available from: SARTI SPROGIS, Adriane Cristina. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. 2014. 131 p. Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/310660>. Acesso em: 24 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/310660.

Council of Science Editors:

Sarti Sprogis, Adriane Cristina 1. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. [Masters Thesis]. Universidade Estadual de Campinas; 2014. Available from: SARTI SPROGIS, Adriane Cristina. Papel dos bacteriófagos na dinâmica populacional de S. enterica I,4,[5],12:i:- e de S. enterica Enteritidis. 2014. 131 p. Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas, Campinas, SP. Disponível em: <http://www.repositorio.unicamp.br/handle/REPOSIP/310660>. Acesso em: 24 ago. 2018. ; http://repositorio.unicamp.br/jspui/handle/REPOSIP/310660

23. Lanhede, Daniel. Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå.

Degree: Mathematics and Mathematical Statistics, 2015, Umeå University

Statistical process control (SPC) is a toolbox to detect changes in the output of a process distribution. It can serve as a valuable resource… (more)

Subjects/Keywords: Statistical process control (SPC); non-parametric; distribution-free; control charts; Phase I analysis; Phase II analysis; Recursive segmentation and permutation (RS/P); change-point model (CPM)

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Lanhede, D. (2015). Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå. (Thesis). Umeå University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-104512

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Lanhede, Daniel. “Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå.” 2015. Thesis, Umeå University. Accessed April 10, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-104512.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Lanhede, Daniel. “Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå.” 2015. Web. 10 Apr 2021.

Vancouver:

Lanhede D. Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå. [Internet] [Thesis]. Umeå University; 2015. [cited 2021 Apr 10]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-104512.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Lanhede D. Non-parametric Statistical Process Control : Evaluation and Implementation of Methods for Statistical Process Control at GE Healthcare, Umeå. [Thesis]. Umeå University; 2015. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-104512

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of California – Irvine

24. Kim, Steven. Bayesian Dose-Response Modeling in Sparse Data.

Degree: Statistics, 2015, University of California – Irvine

 This book discusses Bayesian dose-response modeling in small samples applied to two different settings. The first setting is early phase clinical trials, and the second… (more)

Subjects/Keywords: Statistics; Adaptive designs; Bayesian decision theory; Dose-response modeling; Hormesis; Phase I clinical trials; Sequential decisions

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, S. (2015). Bayesian Dose-Response Modeling in Sparse Data. (Thesis). University of California – Irvine. Retrieved from http://www.escholarship.org/uc/item/35z6p002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kim, Steven. “Bayesian Dose-Response Modeling in Sparse Data.” 2015. Thesis, University of California – Irvine. Accessed April 10, 2021. http://www.escholarship.org/uc/item/35z6p002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kim, Steven. “Bayesian Dose-Response Modeling in Sparse Data.” 2015. Web. 10 Apr 2021.

Vancouver:

Kim S. Bayesian Dose-Response Modeling in Sparse Data. [Internet] [Thesis]. University of California – Irvine; 2015. [cited 2021 Apr 10]. Available from: http://www.escholarship.org/uc/item/35z6p002.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kim S. Bayesian Dose-Response Modeling in Sparse Data. [Thesis]. University of California – Irvine; 2015. Available from: http://www.escholarship.org/uc/item/35z6p002

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

25. Piha-Paul, Sarina A. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.

Degree: MS, 2010, Texas Medical Center

 Treatment for cancer often involves combination therapies used both in medical practice and clinical trials. Korn and Simon listed three reasons for the utility of… (more)

Subjects/Keywords: phase I; trial design; bevacizumab. temsirolimus; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Piha-Paul, S. A. (2010). An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. (Thesis). Texas Medical Center. Retrieved from https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Piha-Paul, Sarina A. “An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.” 2010. Thesis, Texas Medical Center. Accessed April 10, 2021. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Piha-Paul, Sarina A. “An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.” 2010. Web. 10 Apr 2021.

Vancouver:

Piha-Paul SA. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. [Internet] [Thesis]. Texas Medical Center; 2010. [cited 2021 Apr 10]. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Piha-Paul SA. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. [Thesis]. Texas Medical Center; 2010. Available from: https://digitalcommons.library.tmc.edu/utgsbs_dissertations/72

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

26. Milojkovic Kerklaan, B. Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma.

Degree: 2015, Universiteit Utrecht

 Chemotherapy is a very frequently used therapy in patients with advanced tumors with or without central nervous system (CNS) metastases or primary brain tumors. Despite… (more)

Subjects/Keywords: phase I/II studies; pharmacokinetics; oral chemotherapy; solid tumors; CNS tumors; blood-brain barrier; glioma; brain metastases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Milojkovic Kerklaan, B. (2015). Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/318806

Chicago Manual of Style (16th Edition):

Milojkovic Kerklaan, B. “Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma.” 2015. Doctoral Dissertation, Universiteit Utrecht. Accessed April 10, 2021. http://dspace.library.uu.nl:8080/handle/1874/318806.

MLA Handbook (7th Edition):

Milojkovic Kerklaan, B. “Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma.” 2015. Web. 10 Apr 2021.

Vancouver:

Milojkovic Kerklaan B. Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2015. [cited 2021 Apr 10]. Available from: http://dspace.library.uu.nl:8080/handle/1874/318806.

Council of Science Editors:

Milojkovic Kerklaan B. Novel systemic treatment options for advanced solid tumors with or without central nervous system metastases or malignant glioma. [Doctoral Dissertation]. Universiteit Utrecht; 2015. Available from: http://dspace.library.uu.nl:8080/handle/1874/318806

27. Bin Zawawi, Muhammad Nazrol. Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar.

Degree: Docteur es, Électronique, 2015, Nice

L’objectif de cette thèse est de concevoir un réseau réflecteur à dépointage électronique à 20 GHz pour des applications de communication avec des drones (Unmanned… (more)

Subjects/Keywords: Antennes à réseau réflecteur; Antennes à circuit imprimé; Déphaseurs; Reflectarray; Millimetre wave; Printed circuit antenna; P-i-n diode; Phase shifter

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bin Zawawi, M. N. (2015). Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar. (Doctoral Dissertation). Nice. Retrieved from http://www.theses.fr/2015NICE4017

Chicago Manual of Style (16th Edition):

Bin Zawawi, Muhammad Nazrol. “Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar.” 2015. Doctoral Dissertation, Nice. Accessed April 10, 2021. http://www.theses.fr/2015NICE4017.

MLA Handbook (7th Edition):

Bin Zawawi, Muhammad Nazrol. “Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar.” 2015. Web. 10 Apr 2021.

Vancouver:

Bin Zawawi MN. Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar. [Internet] [Doctoral dissertation]. Nice; 2015. [cited 2021 Apr 10]. Available from: http://www.theses.fr/2015NICE4017.

Council of Science Editors:

Bin Zawawi MN. Nouvelles antennes pourr radar millimétriques : New antenna for millimetre wave radar. [Doctoral Dissertation]. Nice; 2015. Available from: http://www.theses.fr/2015NICE4017


Baylor University

28. Pruszynski, Jessica E. Bayesian models for discrete censored sampling and dose finding.

Degree: PhD, Statistical Sciences., 2010, Baylor University

 We first consider the problem of discrete censored sampling. Censored binomial data may lead to irregular likelihood functions and problems with statistical inference. We consider… (more)

Subjects/Keywords: Bayesian methods.; Discrete censored sampling.; Phase I clinical trials.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Pruszynski, J. E. (2010). Bayesian models for discrete censored sampling and dose finding. (Doctoral Dissertation). Baylor University. Retrieved from http://hdl.handle.net/2104/7959

Chicago Manual of Style (16th Edition):

Pruszynski, Jessica E. “Bayesian models for discrete censored sampling and dose finding.” 2010. Doctoral Dissertation, Baylor University. Accessed April 10, 2021. http://hdl.handle.net/2104/7959.

MLA Handbook (7th Edition):

Pruszynski, Jessica E. “Bayesian models for discrete censored sampling and dose finding.” 2010. Web. 10 Apr 2021.

Vancouver:

Pruszynski JE. Bayesian models for discrete censored sampling and dose finding. [Internet] [Doctoral dissertation]. Baylor University; 2010. [cited 2021 Apr 10]. Available from: http://hdl.handle.net/2104/7959.

Council of Science Editors:

Pruszynski JE. Bayesian models for discrete censored sampling and dose finding. [Doctoral Dissertation]. Baylor University; 2010. Available from: http://hdl.handle.net/2104/7959


Freie Universität Berlin

29. Kupser, Peter. Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase.

Degree: 2011, Freie Universität Berlin

 Schwingungsspektroskopie ist eine gebräuchliche Methode zur Strukturaufklärung von Biomolekülen in der kondensierten Phase. Schwingungsmoden, wie zum Beispiel die C−O Streckschwingung (Amid-I Bande) im Bereich von… (more)

Subjects/Keywords: infrared spectroscopy; secondary structure; gas phase; biomolecules; amide-I; helix; sheet; coiled coil; mass spectrometry; 500 Naturwissenschaften und Mathematik::530 Physik

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kupser, P. (2011). Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase. (Thesis). Freie Universität Berlin. Retrieved from http://dx.doi.org/10.17169/refubium-13852

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kupser, Peter. “Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase.” 2011. Thesis, Freie Universität Berlin. Accessed April 10, 2021. http://dx.doi.org/10.17169/refubium-13852.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kupser, Peter. “Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase.” 2011. Web. 10 Apr 2021.

Vancouver:

Kupser P. Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase. [Internet] [Thesis]. Freie Universität Berlin; 2011. [cited 2021 Apr 10]. Available from: http://dx.doi.org/10.17169/refubium-13852.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kupser P. Infrarotspektroskopie zur Charakterisierung von Sekundärstrukturelementen von Biomolekülen in der Gasphase. [Thesis]. Freie Universität Berlin; 2011. Available from: http://dx.doi.org/10.17169/refubium-13852

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Lund

30. Leon, Otilia. Improved oncological treatment of anal cancer.

Degree: 2019, University of Lund

 AbstractBackground: Squamous cell cancer of the anus (SCCA) is a rare malignancy, but the incidence is increasing. It isassociated with humman papilloma virus infection. The… (more)

Subjects/Keywords: Medical and Health Sciences; Anal cancer; chemotherapy; Radiotherapy; Prognosis and survival; phase I/II trial; Cetuximab; metastatic

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Leon, O. (2019). Improved oncological treatment of anal cancer. (Doctoral Dissertation). University of Lund. Retrieved from https://lup.lub.lu.se/record/fb100283-a48a-4886-88c3-c5654d33b5a3 ; https://portal.research.lu.se/ws/files/61679568/Improved_oncological_treatment_of_anal_cancer_Otilia_Leon.pdf

Chicago Manual of Style (16th Edition):

Leon, Otilia. “Improved oncological treatment of anal cancer.” 2019. Doctoral Dissertation, University of Lund. Accessed April 10, 2021. https://lup.lub.lu.se/record/fb100283-a48a-4886-88c3-c5654d33b5a3 ; https://portal.research.lu.se/ws/files/61679568/Improved_oncological_treatment_of_anal_cancer_Otilia_Leon.pdf.

MLA Handbook (7th Edition):

Leon, Otilia. “Improved oncological treatment of anal cancer.” 2019. Web. 10 Apr 2021.

Vancouver:

Leon O. Improved oncological treatment of anal cancer. [Internet] [Doctoral dissertation]. University of Lund; 2019. [cited 2021 Apr 10]. Available from: https://lup.lub.lu.se/record/fb100283-a48a-4886-88c3-c5654d33b5a3 ; https://portal.research.lu.se/ws/files/61679568/Improved_oncological_treatment_of_anal_cancer_Otilia_Leon.pdf.

Council of Science Editors:

Leon O. Improved oncological treatment of anal cancer. [Doctoral Dissertation]. University of Lund; 2019. Available from: https://lup.lub.lu.se/record/fb100283-a48a-4886-88c3-c5654d33b5a3 ; https://portal.research.lu.se/ws/files/61679568/Improved_oncological_treatment_of_anal_cancer_Otilia_Leon.pdf

[1] [2] [3] [4] [5]

.